Oncotarget is a multidisciplinary peer-reviewed open-access medical journal that publishes papers online in a weekly issue. The term “oncotarget” represents all pathways, molecules and cellular functions common in cancer and aging, lymphocytes and neurons, cancer cells and microbes, neurodegeneration and atherosclerosis. Oncotarget, which is published by Impact Journals, was founded in 2010. Its editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov. Members of the editorial board include Carlo M. Croce, the former editor-in-chief of Cancer Research and the Nobel Prize winner, Andrew Schally among many others. Oncotarget has produced four notable members. They are, Michael N. Hall, Bert Vogelstein, Stephen J. Elledge and Alexander Varshavsky who won the highly coveted Breakthrough Prize.
The journal’s increasing popularity has been brought about by educational, constructive,, insightful and multiple-review, which helps authors to boost the impact of their research. Their mission is to increase the availability of scientific research to a wider audience. They strive to utilize insightful review to achieve maximum impact of research and allow faster sharing of exceptional discoveries. The journal intends to break the barrier between specialties and connect diverse fields of biomedical science, while promoting applications of basic clinical science to find cures for diseases. Oncotarget accept papers beyond oncology. They cover broad topics, including pharmacology, cardiology, neuroscience, endocrinology, metabolism, immunology and microbiology, autophagy and cell death, and chromosome among others. Check Oncotarget in dovepress.com.
Authors are required to describe their results accurately and include an objective discussion of their original work. They may be requested to provide raw data and be ready to share the information with the public. They are also not required to submit research papers that had already been published in another journal. Editors evaluate papers strictly based on their scientific merit regardless of authors’ race, gender, citizenship or sexual orientation. Editors adhere to confidentiality of the manuscripts and do not use unpublished content for their personal use. They ensure that accepted papers are reviewed by at least two experts in the field of study before publishing. Only qualified reviewers are allowed to review manuscripts, which they are not allowed to discuss with unauthorized members. Reviews help authors to improve their work. However, personal criticism is not allowed.